Benchmark Research   Report issue

For profit Phase 2 Phase 3
Founded: Fort Worth TX United States (1997)

Organization Overview

First Clinical Trial
2006
NCT00332956
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Benchmark Research - Fort Worth | Benchmark Research, Fort Worth, TX